JP2013515685A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013515685A5 JP2013515685A5 JP2012545114A JP2012545114A JP2013515685A5 JP 2013515685 A5 JP2013515685 A5 JP 2013515685A5 JP 2012545114 A JP2012545114 A JP 2012545114A JP 2012545114 A JP2012545114 A JP 2012545114A JP 2013515685 A5 JP2013515685 A5 JP 2013515685A5
- Authority
- JP
- Japan
- Prior art keywords
- pyridin
- pyrrolo
- amino
- pyrazol
- pyrimidin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- KAPVOBABOGXFBG-UHFFFAOYSA-N CC(c1ccccc1)(c1cc(-c(c2c3)c[nH]c2ncc3-c2c[n](CCC(O)=O)nc2)nc(N)n1)O Chemical compound CC(c1ccccc1)(c1cc(-c(c2c3)c[nH]c2ncc3-c2c[n](CCC(O)=O)nc2)nc(N)n1)O KAPVOBABOGXFBG-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102009060174.0 | 2009-12-23 | ||
| DE102009060174A DE102009060174A1 (de) | 2009-12-23 | 2009-12-23 | Pyrrolopyridinyl-pyrimidin-2-yl-amin-derivate |
| PCT/EP2010/006911 WO2011076316A1 (de) | 2009-12-23 | 2010-11-12 | Pyrrolopyridinyl-pyrimidin-2-yl-amin-derivate |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013515685A JP2013515685A (ja) | 2013-05-09 |
| JP2013515685A5 true JP2013515685A5 (enExample) | 2013-12-26 |
| JP5847091B2 JP5847091B2 (ja) | 2016-01-20 |
Family
ID=43531962
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012545114A Expired - Fee Related JP5847091B2 (ja) | 2009-12-23 | 2010-11-12 | ピロロピリジニルピリミジン−２−イルアミン誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8575163B2 (enExample) |
| EP (1) | EP2516431B1 (enExample) |
| JP (1) | JP5847091B2 (enExample) |
| CN (1) | CN102666538B (enExample) |
| AR (1) | AR079569A1 (enExample) |
| AU (1) | AU2010335628B2 (enExample) |
| CA (1) | CA2785307C (enExample) |
| DE (1) | DE102009060174A1 (enExample) |
| ES (1) | ES2537412T3 (enExample) |
| WO (1) | WO2011076316A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2011320565A1 (en) | 2010-10-28 | 2013-05-23 | Innocrin Pharmaceuticals, Inc. | Metalloenzyme inhibitor compounds |
| DE102010050558A1 (de) * | 2010-11-05 | 2012-05-10 | Merck Patent Gmbh | 1H-Pyrrolo[2,3-b]pyridinderivate |
| DE102010053347A1 (de) * | 2010-12-03 | 2012-06-06 | Merck Patent Gmbh | 3-Hetaryl-substituierte Pyrrolo[2,3-b] pyridin-derivative als PDK1-Inhibitoren |
| US8809372B2 (en) | 2011-09-30 | 2014-08-19 | Asana Biosciences, Llc | Pyridine derivatives |
| EP2760833A1 (en) * | 2011-09-30 | 2014-08-06 | Endo Pharmaceuticals Inc. | Pyridine derivatives |
| CN107550905B (zh) * | 2017-09-11 | 2020-07-17 | 浙江永宁药业股份有限公司 | 多取代吡咯并吡啶类化合物的药物用途及其制备方法 |
| JP2022507514A (ja) * | 2018-11-16 | 2022-01-18 | カリフォルニア インスティチュート オブ テクノロジー | Ｅｒｋインヒビター及びその使用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5747469A (en) | 1991-03-06 | 1998-05-05 | Board Of Regents, The University Of Texas System | Methods and compositions comprising DNA damaging agents and p53 |
| GB9904387D0 (en) | 1999-02-25 | 1999-04-21 | Pharmacia & Upjohn Spa | Antitumour synergistic composition |
| GB0308466D0 (en) | 2003-04-11 | 2003-05-21 | Novartis Ag | Organic compounds |
| PL1730146T3 (pl) * | 2004-03-30 | 2011-10-31 | Vertex Pharma | Azaindole użyteczne jako inhibitor JAK i innych kinaz białkowych |
| DE102007028515A1 (de) | 2007-06-21 | 2008-12-24 | Merck Patent Gmbh | 6-(Pyrrolopyridinyl)-pyrimidinyl-2-amin-derivate |
| DE102008031517A1 (de) * | 2008-07-03 | 2010-01-07 | Merck Patent Gmbh | Pyrrolopyridinyl-pyrimidin-2-yl-amin-derivate |
-
2009
- 2009-12-23 DE DE102009060174A patent/DE102009060174A1/de not_active Withdrawn
-
2010
- 2010-11-12 EP EP10778880.4A patent/EP2516431B1/de not_active Not-in-force
- 2010-11-12 US US13/518,726 patent/US8575163B2/en not_active Expired - Fee Related
- 2010-11-12 JP JP2012545114A patent/JP5847091B2/ja not_active Expired - Fee Related
- 2010-11-12 AU AU2010335628A patent/AU2010335628B2/en not_active Ceased
- 2010-11-12 CN CN201080058668.1A patent/CN102666538B/zh not_active Expired - Fee Related
- 2010-11-12 CA CA2785307A patent/CA2785307C/en not_active Expired - Fee Related
- 2010-11-12 WO PCT/EP2010/006911 patent/WO2011076316A1/de not_active Ceased
- 2010-11-12 ES ES10778880.4T patent/ES2537412T3/es active Active
- 2010-12-20 AR ARP100104796A patent/AR079569A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013515685A5 (enExample) | ||
| US11613538B2 (en) | Method of inhibiting or reducing a viral infection | |
| US8765748B2 (en) | Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancer | |
| KR101985984B1 (ko) | 키나아제 저해제로서의 벤조니트릴 유도체 | |
| US10358436B2 (en) | Kinase inhibitors and method of treating cancer | |
| EP2800742B1 (en) | 4,4-disubstituted-1,4-dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis b | |
| EP4267575A1 (en) | Compounds for degrading cyclin-dependent kinase 2 via ubiquitin proteosome pathway | |
| HRP20140953T1 (hr) | Morfolino pirimidini i njihova uporaba za lijeäśenje | |
| JP2016535000A5 (enExample) | ||
| EP1415987A1 (en) | Nitrogenous aromatic ring compounds | |
| RU2009104340A (ru) | Производные [4,5']бипиримидинил-6,4'-диамина в качестве ингибиторов протеинкиназы | |
| JP2016519685A5 (enExample) | ||
| KR20150128839A (ko) | 헤테로시클릭 화합물 및 그의 용도 | |
| JP2009529047A5 (enExample) | ||
| JP2017527548A5 (enExample) | ||
| KR20180073599A (ko) | Btk 억제 활성을 갖는 피리미딘 및 피리딘 화합물을 사용하여 암 치료하는 방법 | |
| JP2014520885A5 (enExample) | ||
| JP2014526499A5 (enExample) | ||
| JP2013518904A5 (enExample) | ||
| JP5847091B2 (ja) | ピロロピリジニルピリミジン−２−イルアミン誘導体 | |
| SI3174881T1 (en) | (1,2,4) triazolo (4,3-B) pyridazines for use in the treatment of proliferative diseases | |
| EA014779B1 (ru) | Производные хиназолина в качестве mtki | |
| EP4543889A1 (en) | Bifunctional compounds containing pyrido[2,3-djpyrimidin-7(8h)-one derivatives for degrading cyclin-dependent kinase 2 via ubiquitin proteasome pathway | |
| JP2012508225A5 (enExample) | ||
| JPWO2019215316A5 (enExample) |